News
Multimedia
Publication
Conferences
Resources
Subscribe
Webcasts

Spotlight -

Downstream Processing|

Upstream Processing

Jimmy Xin

Jimmy Xin is scientist at Vector Process Development, ElevateBio.

Articles by Jimmy Xin

David Crockett/Stock.Adobe.com – Rapid growth in cell-based immuno-oncology pipelines and early development efforts with in-vivo lentiviral vector-based therapies are fueling CGT growth.

Tactics and Strategies for Designing an Ideal Lentiviral Vector Platform

ByBojiao Yin,Mercedes Segura Gally,Jimmy Xin,James Fasano

March 1st 2023

There is growing pressure for robust and economically scalable viral-vector manufacturing technologies.

Latest Updated Articles

Trending on BioPharm International

What a High-Dose Nusinersen Option Means for Future SMA Care

Implications of the First Liquid IV Infliximab Biosimilar

Integrated Services for the Whole Drug Development Pathway

Weighing Digitalization Efficiency Against Upskilling and Quality Concerns

© 2025 MJH Life Sciences^®

All rights reserved.